221 related articles for article (PubMed ID: 34286555)
1. The new patterns of nephrolithiasis: What has been changing in the last millennium?
Cicerello E; Ciaccia M; Cova GD; Mangano MS
Arch Ital Urol Androl; 2021 Jun; 93(2):195-199. PubMed ID: 34286555
[TBL] [Abstract][Full Text] [Related]
2. Nephrolithiasis and loss of kidney function.
Keddis MT; Rule AD
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):390-6. PubMed ID: 23736840
[TBL] [Abstract][Full Text] [Related]
3. Effect of being overweight on urinary metabolic risk factors for kidney stone formation.
Shavit L; Ferraro PM; Johri N; Robertson W; Walsh SB; Moochhala S; Unwin R
Nephrol Dial Transplant; 2015 Apr; 30(4):607-13. PubMed ID: 25362001
[TBL] [Abstract][Full Text] [Related]
4. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.
Dhondup T; Kittanamongkolchai W; Vaughan LE; Mehta RA; Chhina JK; Enders FT; Hickson LJ; Lieske JC; Rule AD
Am J Kidney Dis; 2018 Dec; 72(6):790-797. PubMed ID: 30146423
[TBL] [Abstract][Full Text] [Related]
5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
6. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
Am J Kidney Dis; 2004 Nov; 44(5):799-805. PubMed ID: 15492945
[TBL] [Abstract][Full Text] [Related]
7. Obesity and urolithiasis: evidence of regional influences.
Trinchieri A; Croppi E; Montanari E
Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
[TBL] [Abstract][Full Text] [Related]
8. Influence of BMI in nephrolithiasis in an Appalachian pediatric population: A single-center experience.
Murphy MO; Erpelding SG; Chishti AS; Dugan A; Ziada A; Kiessling SG
J Pediatr Urol; 2018 Aug; 14(4):330.e1-330.e8. PubMed ID: 29887297
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Syndrome and Kidney Stone Disease: A Systematic Review of Literature.
Wong Y; Cook P; Roderick P; Somani BK
J Endourol; 2016 Mar; 30(3):246-53. PubMed ID: 26576717
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors for urolithiasis].
Mohebbi N
Ther Umsch; 2021 Jun; 78(5):223-227. PubMed ID: 34032133
[TBL] [Abstract][Full Text] [Related]
11. Obesity and metabolic stone disease.
Wollin DA; Skolarikos A; Preminger GM
Curr Opin Urol; 2017 Sep; 27(5):422-427. PubMed ID: 28650866
[TBL] [Abstract][Full Text] [Related]
12. Obesity and kidney stone disease: a systematic review.
Carbone A; Al Salhi Y; Tasca A; Palleschi G; Fuschi A; De Nunzio C; Bozzini G; Mazzaferro S; Pastore AL
Minerva Urol Nefrol; 2018 Aug; 70(4):393-400. PubMed ID: 29856171
[TBL] [Abstract][Full Text] [Related]
13. Metabolic diagnosis in stone formers in relation to body mass index.
Del Valle EE; Negri AL; Spivacow FR; Rosende G; Forrester M; Pinduli I
Urol Res; 2012 Feb; 40(1):47-52. PubMed ID: 21660441
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and medical management of kidney stones in children.
Tasian GE; Copelovitch L
J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
[TBL] [Abstract][Full Text] [Related]
15. [Nephrolithiasis-induced ESRD: frequency, causes and prevention].
Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
Nephrol Ther; 2005 Nov; 1(5):301-10. PubMed ID: 16895699
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome: a multifaceted risk factor for kidney stones.
Domingos F; Serra A
Scand J Urol; 2014 Oct; 48(5):414-9. PubMed ID: 24708398
[TBL] [Abstract][Full Text] [Related]
17. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.
Sakhaee K; Maalouf NM; Sinnott B
J Clin Endocrinol Metab; 2012 Jun; 97(6):1847-60. PubMed ID: 22466339
[TBL] [Abstract][Full Text] [Related]
18. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
[TBL] [Abstract][Full Text] [Related]
19. Uric acid nephrolithiasis: An update.
Cicerello E
Urologia; 2018 Aug; 85(3):93-98. PubMed ID: 29687761
[TBL] [Abstract][Full Text] [Related]
20. 24-h urine metabolic profile: is it necessary in all kidney stone formers?
Abu-Ghanem Y; Shvero A; Kleinmann N; Winkler HZ; Zilberman DE
Int Urol Nephrol; 2018 Jul; 50(7):1243-1247. PubMed ID: 29876775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
